Stemline Therapeutics Inc (NASDAQ:STML)

13.05
Delayed Data
As of May 22
 -0.20 / -1.51%
Today’s Change
10.50
Today|||52-Week Range
18.94
-23.51%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hoberman Kenneth
Chief Operating Officer
Sale3/19/201517,307$16.43$284.4K-19.34%
Bergstein Ivan
Chief Executive Officer
Sale11/26/201411,974$14.40$172.4K-11.76%
Hoberman Kenneth
Chief Operating Officer
Buy3/19/201527,105$4.09$110.9K-19.34%
Gionco David G
Chief Accounting Officer
Sale1/20/20153,311$14.22$47.1K-8.55%
Bergstein Ivan
Chief Executive Officer
Sale2/18/20153,180$14.02$44.6K-7.32%
Rowinsky Eric K
Chief Medical Officer
Sale2/18/20151,640$13.99$22.9K-7.32%
Bentsur Ronald
Director
Sale3/18/20151,388$16.12$22.4K-18.08%
Hoberman Kenneth
Chief Operating Officer
Sale2/18/20151,593$14.02$22.3K-7.32%
Bentsur Ronald
Director
Buy3/18/20155,421$4.09$22.2K-18.08%
Bergstein Ivan
Chief Executive Officer
Buy9/03/20142,000$11.05$22.1K+19.51%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account